Skip Navigation LinksHome > October 2008 - Volume 12 - Issue 4 > The Accuracy of the Papanicolaou Smear in the Screening and...
Journal of Lower Genital Tract Disease:
doi: 10.1097/LGT.0b013e31816b44bc
Original Articles

The Accuracy of the Papanicolaou Smear in the Screening and Diagnostic Settings

Cárdenas-Turanzas, Marylou MD, DrPH1; Follen, Michele MD, PhD2; Nogueras-Gonzalez, Graciela M. MPH1; Benedet, J.L. MD3; Beck, J. Robert MD4; Cantor, Scott B. PhD1

Spanish Translation
Collapse Box

Abstract

Objective. We evaluated the performance of the Papanicolaou smear in screening and diagnostic settings.

Study Design. We analyzed Papanicolaou smear results of 1,850 women recruited into a clinical trial to evaluate an emerging technology for the detection of cervical cancer. Screening and diagnosis groups were based on the history of previous Papanicolaou smear results. We calculated sensitivities, specificities, positive and negative likelihood ratios (LR+ and LR−), receiver operating characteristic curves, and areas under the receiver operating characteristic curve (AUC).

Results. In the screening group, by defining disease as cervical intraepithelial neoplasia (CIN) 2,3/cancer or worse and using high-grade squamous intraepithelial lesion (HSIL) as the test cutpoint, the AUC was 0.689, and the LR+ and LR− were 39.25 and 0.67, respectively. In the diagnosis group, the AUC was 0.764, and the LR+ and LR− were 3.79 and 0.56, respectively. By defining disease as human papillomavirus/CIN 1 or worse and HSIL as the test cutpoint, the AUC was 0.586, and the LR+ and LR− were 17.01 and 0.92 in the screening group; in the diagnosis group, the AUC was 0.686, and the LR+ and LR− were 2.77 and 0.75, respectively.

Conclusions. In a screening setting, a Papanicolaou smear result of HSIL or worse is 39 times more likely in a patient with CIN 2,3/cancer than in a patient without it. This compares to 4 times more likely in the diagnostic setting. The magnitude of the positive likelihood ratio observed in the screening group indicated that abnormal Papanicolaou smear results obtained in the screening setting should have more impact on clinical decision making than those from results obtained in the diagnostic setting.

©2008The American Society for Colposcopy and Cervical Pathology

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.